![Shawn Cavanagh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shawn Cavanagh
Directeur/Membre du Conseil chez
ThorpeWood, Inc.
Profil
Shawn P.
Cavanagh is currently Director at ThorpeWood, Inc., Director at Kindeva Drug Delivery LP since 2021, and Operating Partner at Altaris Capital Partners LLC since 2021.
Former roles include President, Chief Operating Officer & Director at Cambrex Corp.
in 2020, Director at Cambrex Charles City, Inc., Vice President-Bioproducts at Cambrex Corp.
from 2005 to 2007, and President-Lonza Bioscience at Lonza, Inc. from 2007 to 2009.
Education includes an undergraduate degree from the University of New Hampshire, conferred in 1988.
Postes actifs de Shawn Cavanagh
| Sociétés | Poste | Début |
|---|---|---|
ThorpeWood, Inc. | Directeur/Membre du Conseil | - |
Altaris Capital Partners LLC
 Altaris Capital Partners LLC Investment ManagersFinance Altaris Capital Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical devices & diagnostics, pharmaceuticals & life sciences and tech-enabled service. It provides financing for acquisitions, corporate carve-outs and partnerships. It also uses debt financing and makes majority and minority investments. | Private Equity Investor | 01/05/2021 |
Kindeva Drug Delivery LP
 Kindeva Drug Delivery LP Medical SpecialtiesHealth Technology Operates as a drug delivery contract development and manufacturing organization | Directeur/Membre du Conseil | 01/01/2021 |
Anciens postes connus de Shawn Cavanagh
| Sociétés | Poste | Fin |
|---|---|---|
| CAMBREX CORPORATION | President | 30/06/2020 |
Lonza, Inc.
 Lonza, Inc. Chemicals: SpecialtyProcess Industries Provides chemical ingredient products | Corporate Officer/Principal | 01/04/2009 |
| CAMBREX CORPORATION | Corporate Officer/Principal | 01/01/2007 |
Cambrex Charles City, Inc.
 Cambrex Charles City, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Formation de Shawn Cavanagh
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Develops and manufactures drug substances | Health Technology |
Lonza, Inc.
Lonza, Inc. Chemicals: SpecialtyProcess Industries Provides chemical ingredient products | Process Industries |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altaris Capital Partners LLC
Altaris Capital Partners LLC Investment ManagersFinance Altaris Capital Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical devices & diagnostics, pharmaceuticals & life sciences and tech-enabled service. It provides financing for acquisitions, corporate carve-outs and partnerships. It also uses debt financing and makes majority and minority investments. | Finance |
Cambrex Charles City, Inc.
Cambrex Charles City, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ThorpeWood, Inc. | |
Kindeva Drug Delivery LP
Kindeva Drug Delivery LP Medical SpecialtiesHealth Technology Operates as a drug delivery contract development and manufacturing organization | Health Technology |
